LogicBio Therapeutics (LOGC) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: +42.9%
Financial Fact:
Loss from operations: -140.8K
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.04).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GTCR Is Said To Be In Talks To Buy Software Maker SPS Commerce - Bloomberg
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
